These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21595268)

  • 21. Neuroprotective properties of GLP-1: theoretical and practical applications.
    Holst JJ; Burcelin R; Nathanson E
    Curr Med Res Opin; 2011 Mar; 27(3):547-58. PubMed ID: 21222567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay.
    Niswender K
    Diabetes Obes Metab; 2010 Apr; 12(4):267-87. PubMed ID: 20380648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects.
    Cefalu WT; Richards RJ; Melendez-Ramirez LY
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S39-47. PubMed ID: 19952302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incretin related drugs].
    Hada Y; Yamauchi T; Kadowaki T
    Nihon Rinsho; 2010 Oct; 68(10):1900-5. PubMed ID: 20954337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newly approved and promising antidiabetic agents.
    Combettes M; Kargar C
    Therapie; 2007; 62(4):293-310. PubMed ID: 17983555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Emerging GLP-1 analogues and dipeptidyl peptidase 4(DPP-4) inhibitors].
    Ohsugi M
    Nihon Rinsho; 2011 May; 69(5):895-901. PubMed ID: 21595278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular complications of diabetes].
    Nishio Y
    Nihon Rinsho; 2015 Dec; 73(12):2053-8. PubMed ID: 26666152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tight blood glucose control pays off in reduced cardiovascular risk in diabetes.
    Friedrich MJ
    JAMA; 2006 Sep; 296(12):1455-6. PubMed ID: 17003387
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1.
    Sonne DP; Knop FK
    Exp Biol Med (Maywood); 2013 Oct; 238(10):1116-7. PubMed ID: 24174423
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardio-diabetology: The new 'sweetheart' in cardiovascular prevention.
    Aboyans V; Cosentino F
    Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):5-6. PubMed ID: 31766919
    [No Abstract]   [Full Text] [Related]  

  • 32. Preventing macrovascular complications of diabetes: where do we stand with glycemic control?
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Expert Opin Investig Drugs; 2008 Dec; 17(12):1777-9. PubMed ID: 19012494
    [No Abstract]   [Full Text] [Related]  

  • 33. Incretin therapy and pancreatic pathologies: background pathology versus drug-induced pathology in rats.
    Egan JM; Chia CW
    Diabetes; 2014 Apr; 63(4):1174-8. PubMed ID: 24651798
    [No Abstract]   [Full Text] [Related]  

  • 34. DIABETES CARE. THINK ON YOUR FEET.
    Trueland J
    Health Serv J; 2015 Oct; 125(6462):25-6. PubMed ID: 26875420
    [No Abstract]   [Full Text] [Related]  

  • 35. Early detection of vascular disease in diabetes.
    WOOLAM GL
    Med Rec Ann; 1962 May; 55():86-7. PubMed ID: 14008269
    [No Abstract]   [Full Text] [Related]  

  • 36. Success stories: studying long lives with diabetes for clues to avoiding complications.
    Curry A
    Diabetes Forecast; 2014 Mar; 67(3):72-3. PubMed ID: 24730186
    [No Abstract]   [Full Text] [Related]  

  • 37. Advance in diagnosis of peripheral diseases.
    HARPUDER K
    NY Med; 1951 Feb; 7(3):16-7; passim. PubMed ID: 14806809
    [No Abstract]   [Full Text] [Related]  

  • 38. Dying with cardiovascular disease, not of it.
    Wann S
    Trends Cardiovasc Med; 2015 Jul; 25(5):443-4. PubMed ID: 25618322
    [No Abstract]   [Full Text] [Related]  

  • 39. [Heart and blood vessels in 1950].
    MERKLEN FP; BOUCOMONT R
    Paris Med; 1950 Oct; 40(38):527-32. PubMed ID: 14780717
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of incretin on cardiovascular disease and risk factors].
    Kodama K; Node K
    Nihon Rinsho; 2011 May; 69(5):836-41. PubMed ID: 21595268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.